More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus.
Where this comes from
- Record sourced from PubMed, PMID 37967910.
- Also identified by DOI 10.3899/jrheum.2023-0947.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Systemic lupus erythematosus (SLE) significantly affects different aspects of patients' health-related quality of life (HRQOL).<sup>1</sup> In 1998, Outcome Measures in Rheumatology (OMERACT) proposed the first Core Domain Set (CDS) for SLE, which included disease activity, organ damage, adverse events, HRQOL, and economic costs.<sup>2</sup>.